Renal Involvement in Chronic Graft‐Versus‐Host Disease
European Journal of Haematology · 2025-12 · 115 (6) · 547-554
DOI: 10.1111/ejh.70020 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 14.08.2025. Verfasst von Nihar Desai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Graft versus host disease (GvHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT). While the skin, eyes, mouth, and liver are the most commonly affected organs in chronic GvHD, there is increasing recognition of less typical sites of involvement. Emerging evidence suggests that the kidney may also be affected; however, current data remain limited and largely derived from small retrospective studies or case series. We examined a cohort of 1441 patients transplanted and identified 12 patients (0.8%) presenting with nephrotic syndrome that had renal biopsies consistent with membranous nephropathy (MN). None of the patients had pre‐existing renal disease. All patients had nephrotic range proteinuria (median 6.6 g/24 h, range 4.1–17.8) at presentation. The median time to diagnosis of glomerular disease was 1.8 years (range 0.6–4.3 years) after HSCT. The median time to diagnosis of nephrotic syndrome was 407 days (range 95–1415 days) after an initial diagnosis of chronic GvHD. Three patients had features of renal vein thrombosis at presentation. All patients showed typical pathologic features of MN with additional mild microangiopathic features on ultrastructural examination, and nine tested were PLA2R negative. All patients received immunosuppressive therapy. Seven had a complete response to treatment, four achieved a partial response, and one did not respond. Herein, we describe their clinical characteristics, disease course, and clinical outcomes. None of our patients developed irreversible renal impairment, outlining the importance of rapid intervention with appropriate immunosuppression. In the absence of effective biomarkers, the management of suspected renal GvHD presenting with proteinuria should include renal biopsy to identify and appropriately classify the lesion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Temerty Faculty of Medicine, University of Toronto, Ontario, Canada.
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
- Department of Pathology, University Health Network, Toronto, Ontario, Canada.
- Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Nihar Desai, Christopher Chan
Zitieren
APA
Desai, N., Law, A. D., Bourlon, C., John, R., Kitchlu, A., Chan, C., Kim, D. D. H., Lipton, J. H., Mattsson, J., & Viswabandya, A. (2025). Renal Involvement in Chronic Graft‐Versus‐Host Disease. European Journal of Haematology, 115(6), 547-554. https://doi.org/10.1111/ejh.70020
Vancouver
Desai N, Law AD, Bourlon C, John R, Kitchlu A, Chan C, et al. Renal Involvement in Chronic Graft‐Versus‐Host Disease. European Journal of Haematology. 2025;115(6):547-554. doi:10.1111/ejh.70020
BibTeX
@article{Desai2025,
author = {Desai, Nihar and Law, Arjun Datt and Bourlon, Christianne and John, Rohan and Kitchlu, Abhijat and Chan, Christopher and Kim, Dennis Dong Hwan and Lipton, Jeffrey H and Mattsson, Jonas and Viswabandya, Auro},
title = {Renal Involvement in Chronic Graft‐Versus‐Host Disease},
journal = {European Journal of Haematology},
year = {2025},
volume = {115},
number = {6},
pages = {547--554},
doi = {10.1111/ejh.70020}
}
EUVIMED